Fox Chase Cancer Center has been ranked among the nation’s best hospitals for urology and urologic oncology, according to U.S. News & World Report.
The publication’s 2026-2027 “Best Hospitals” rankings placed Fox Chase at No. 11 nationally for its delivery of urology care, the best of any program in the Philadelphia region, and the specialty’s highest ranking in Fox Chase Cancer Center’s history.
“We are honored by this recognition, which reflects the extraordinary expertise, dedication, and teamwork across the Fox Chase-Temple Urologic Institute,” said Alexander Kutikov, MD, FACS, chair of the Department of Urology at Fox Chase Cancer Center and co-executive director of the Fox Chase-Temple Urologic Institute. “Rankings are not the goal; the goal is to give every patient access to highly specialized, evidence-based care, advanced technology, and innovative clinical trials, while continually improving outcomes and reducing the burden of treatment.”
“Recognition from U.S. News & World Report is a national acknowledgement that extends beyond the quality of urologic care we provide; it encompasses the breadth of expertise provided by the physicians, surgeons, and clinical staff, as well,” said Jay Simhan, MD, FACS, chair of the Department of Urology at Temple University Hospital and the Lewis Katz School of Medicine at Temple University, and co-executive director of the Fox Chase-Temple Urologic Institute.
Nationally Recognize Expertise in Urology and Urologic Cancers
The Fox Chase-Temple Urologic Institute brings together top-ranked physicians in pursuit of exceptional outcomes for patients who are being treated for common and often-benign conditions like kidney stones and urinary tract infections, as well as complex and challenging cases like bladder cancer and prostate cancer. In fact, nearly all of the Fox Chase-Temple Urologic Institute’s providers are among the region’s “Top Doctors,” according to Philadelphia magazine.
Surgeons at the Urologic Institute leverage advanced technology to support patient care, including minimally invasive procedures to treat a variety of conditions and help patients return to work or daily activities far more quickly, and urodynamics testing that combines real-time imaging and measurements of bladder pressure and function to more precisely evaluate complex urinary disorders.
Fox Chase’s surgical volume in urologic oncology ranks among the highest in Pennsylvania, according to the Pennsylvania Health Care Cost Containment Council's (PHC4) May 2026 report — No. 1 in bladder and kidney cancer surgeries, and No. 3 in prostate cancer surgeries.